BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37084037)

  • 1. Could some mutations of the KIF5A gene be responsible for a dominant CMT2 phenotype? (Case report).
    Dellatte J; Lievens I; Wang FC
    Acta Neurol Belg; 2023 Dec; 123(6):2435-2438. PubMed ID: 37084037
    [No Abstract]   [Full Text] [Related]  

  • 2. Wide phenotypic spectrum in axonal Charcot-Marie-Tooth neuropathy type 2 patients with KIF5A mutations.
    Nam DE; Yoo DH; Choi SS; Choi BO; Chung KW
    Genes Genomics; 2018 Jan; 40(1):77-84. PubMed ID: 29892902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy.
    Liu YT; Laurá M; Hersheson J; Horga A; Jaunmuktane Z; Brandner S; Pittman A; Hughes D; Polke JM; Sweeney MG; Proukakis C; Janssen JC; Auer-Grumbach M; Zuchner S; Shields KG; Reilly MM; Houlden H
    Neurology; 2014 Aug; 83(7):612-9. PubMed ID: 25008398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sural biopsy to detect the axonal cytoskeleton defects in
    Du K; Meng L; Lv H; Zhang W; Wang Z; Yuan Y
    Clin Neuropathol; 2021; 40(3):142-149. PubMed ID: 33155544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth Disease Type 2-Like Phenotype due to a Novel Variant in the Stalk Domain of
    Liouta E; Poulidou V; Frontistis A; Moschou M; Fidani S; Papoulidis I; Spilioti M; Kimiskidis VK; Arnaoutoglou M
    Neurol India; 2023; 71(3):577-579. PubMed ID: 37322770
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2.
    Crimella C; Baschirotto C; Arnoldi A; Tonelli A; Tenderini E; Airoldi G; Martinuzzi A; Trabacca A; Losito L; Scarlato M; Benedetti S; Scarpini E; Spinicci G; Bresolin N; Bassi MT
    Clin Genet; 2012 Aug; 82(2):157-64. PubMed ID: 21623771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing identified novel KIF5A mutations in Chinese patients with amyotrophic lateral sclerosis and Charcot-Marie-Tooth type 2.
    He J; Liu X; Tang L; Zhao C; He J; Fan D
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):326-328. PubMed ID: 31422367
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutation in KIF5A gene associated with hereditary motor and sensory neuropathy and cognitive impairment: a case report and literature review.
    Hong U; Lee J; Choi S; Jang W; Kwon S
    Acta Neurol Belg; 2023 Dec; 123(6):2375-2377. PubMed ID: 36696008
    [No Abstract]   [Full Text] [Related]  

  • 10. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q.
    Kwon JM; Elliott JL; Yee WC; Ivanovich J; Scavarda NJ; Moolsintong PJ; Goodfellow PJ
    Am J Hum Genet; 1995 Oct; 57(4):853-8. PubMed ID: 7573046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild early onset axonal Charcot-Marie-Tooth disease not linked to other axonal Charcot-Marie-Tooth loci.
    Kochanski A; Kennerson M; Kawulak M; Ryniewicz B; Rowinska-Marcinska K; Walizada G; Nowakowski A; Hausmanowa-Petrusewicz I; Nicholson GA
    Neurology; 2005 Feb; 64(3):533-5. PubMed ID: 15699389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic heterogeneity of Charcot-Marie-Tooth disease.
    Hentati A; Lamy C; Melki J; Zuber M; Munnich A; de Recondo J
    Genomics; 1992 Jan; 12(1):155-7. PubMed ID: 1733853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlations of
    de Boer EMJ; van Rheenen W; Goedee HS; Kamsteeg EJ; Brilstra EH; Veldink JH; van Den Berg LH; van Es MA
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):561-570. PubMed ID: 33829936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E.
    De Jonghe P; Mersivanova I; Nelis E; Del Favero J; Martin JJ; Van Broeckhoven C; Evgrafov O; Timmerman V
    Ann Neurol; 2001 Feb; 49(2):245-9. PubMed ID: 11220745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse.
    De Sandre-Giovannoli A; Chaouch M; Kozlov S; Vallat JM; Tazir M; Kassouri N; Szepetowski P; Hammadouche T; Vandenberghe A; Stewart CL; Grid D; Lévy N
    Am J Hum Genet; 2002 Mar; 70(3):726-36. PubMed ID: 11799477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in MYO9B are associated with Charcot-Marie-Tooth disease type 2 neuropathies and isolated optic atrophy.
    Cipriani S; Guerrero-Valero M; Tozza S; Zhao E; Vollmer V; Beijer D; Danzi M; Rivellini C; Lazarevic D; Pipitone GB; Grosz BR; Lamperti C; Marzoli SB; Carrera P; Devoto M; Pisciotta C; Pareyson D; Kennerson M; Previtali SC; Zuchner S; Scherer SS; Manganelli F; Bähler M; Bolino A
    Eur J Neurol; 2023 Feb; 30(2):511-526. PubMed ID: 36260368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland.
    Auranen M; Ylikallio E; Toppila J; Somer M; Kiuru-Enari S; Tyynismaa H
    Neurogenetics; 2013 May; 14(2):123-32. PubMed ID: 23456260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next-generation sequencing reveals further genetic heterogeneity in axonal Charcot-Marie-Tooth neuropathy and a mutation in HSPB1.
    Ylikallio E; Johari M; Konovalova S; Moilanen JS; Kiuru-Enari S; Auranen M; Pajunen L; Tyynismaa H
    Eur J Hum Genet; 2014 Apr; 22(4):522-7. PubMed ID: 23963299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Genome Linkage Analysis with Whole-Exome Sequencing Identifies a Novel Frameshift Variant in NEFH in a Chinese Family with Charcot-Marie-Tooth 2: A Novel Variant in NEFH for Charcot-Marie-Tooth 2.
    Bian X; Lin P; Li J; Long F; Duan R; Yuan Q; Li Y; Gao F; Gao S; Wei S; Li X; Sun W; Gong Y; Yan C; Liu Q
    Neurodegener Dis; 2018; 18(2-3):74-83. PubMed ID: 29587262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of MFN2, GJB1, MPZ and PMP22 in Italian patients with axonal Charcot-Marie-Tooth disease.
    Bergamin G; Boaretto F; Briani C; Pegoraro E; Cacciavillani M; Martinuzzi A; Muglia M; Vettori A; Vazza G; Mostacciuolo ML
    Neuromolecular Med; 2014 Sep; 16(3):540-50. PubMed ID: 24819634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.